Total | UH | GH | PHC | P | SoM | P* | |
---|---|---|---|---|---|---|---|
N = 592 (%) | n = 125 (%) | n = 134 (%) | n = 194 (%) | n = 139 (%) | |||
Score of knowledge of cervical cancer disease | |||||||
Appropriate (>70%) | 329 (55.7) | 75 (60.0) | 80 (59.7) | 113 (58.2) | 0.94 | 61 (43.9) | 0.02 |
Main items of the score of knowledge of cervical cancer disease | |||||||
Most frequent cancer in women† | 587 (99.2) | 123 (98.4) | 133 (99.3) | 193 (99.5) | 0.58 | 138 (99.3) | 0.82 |
Most deadly cancer in women† | 584 (98.6) | 122 (97.6) | 133 (99.3) | 192 (99.0) | 0.44 | 137 (98.6) | 0.66 |
HPV infection (risk factor)† | 409 (69.1) | 98 (78.4) | 85 (63.4) | 128 (66.0) | 0.02 | 98 (70.5) | 0.05 |
Multiparity† | 317 (53.5) | 73 (58.4) | 69 (51.5) | 113 (58.2) | 0.41 | 62 (44.6) | 0.06 |
Post-coital bleeding (symptoms)† | 452 (76.4) | 96 (76.8) | 111 (82.8) | 157 (80.9) | 0.45 | 88 (63.3) | <0.01 |
Score of knowledge of prevention | |||||||
Appropriate (>70%) | 251 (42.4) | 66 (52.8) | 58 (43.3) | 77 (39.7) | 0.05 | 50 (36.0) | 0.03 |
Main items of the score of knowledge of prevention | |||||||
Cervical cancer is preventable | 544 (91.9) | 116 (92.8) | 125 (93.3) | 179 (92.3) | 0.94 | 124 (89.2) | 0.60 |
Screening is a preventive method† | 421 (71.1) | 85 (68.0) | 98 (71.3) | 150 (77.3) | 0.18 | 88 (63.3) | 0.03 |
Aware of visual inspection as screening method | 268 (45.3) | 66 (52.8) | 56 (41.8) | 63 (32.5) | <0.01 | 83 (59.7) | <0.01 |
Vaccine is a preventive method† | 298 (50.3) | 70 (56.0) | 63 (47.0) | 98 (50.5) | 0.41 | 67 (48.2) | 0.57 |
Vaccine administered before sexual debut† | 259 (43.8) | 68 (54.4) | 63 (47.0) | 80 (41.2) | 0.07 | 48 (34.5) | 0.01 |
Vaccine availability in Côte d’Ivoire | 212 (35.8) | 51 (40.8) | 53 (39.6) | 60 (30.9) | 0.12 | 48 (34.5) | 0.23 |